<DOC>
	<DOCNO>NCT00950638</DOCNO>
	<brief_summary>The objective study evaluate safety tolerability ARC1905 intravitreous injection subject geographic atrophy secondary dry age-related macular degeneration ( AMD ) .</brief_summary>
	<brief_title>A Study ARC1905 ( Anti-C5 Aptamer ) Subjects With Dry Age-related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Dry AMD ( drusen and/or geographic atrophy ) eye Any intraocular surgery thermal laser within three ( 3 ) month trial entry . Any prior thermal laser macular region , regardless indication . Any ocular periocular infection ( include blepharitis ) , ocular surface inflammation past twelve ( 12 ) week . History follow procedure : Posterior vitrectomy , filter surgery ( e.g . trabeculectomy ) , glaucoma drainage device , corneal transplant retinal detachment . Any following underlying disease include : Diabetic retinopathy History evidence severe cardiac disease ( e.g. , NYHA Functional Class III IV ) , history clinical evidence unstable angina , acute coronary syndrome , myocardial infarction revascularization within last 6 month , ventricular tachyarrythmias require ongoing treatment . History evidence clinically significant peripheral vascular disease , intermittent claudication prior amputation . Clinically significant impaired renal ( serum creatinine &gt; 2.5 mg/dl status post renal transplant receive dialysis ) hepatic function . Subjects result outside range may enrol consultation Ophthotech . Stroke ( within 12 month trial entry ) . Any major surgical procedure within one month trial entry . Previous therapeutic radiation region study eye . Any treatment investigational agent past 60 day condition . Women pregnant nursing . Known serious allergy fluorescein dye use angiography component ARC1905 formulation .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>AMD</keyword>
</DOC>